Pharmacokinetics of nirmatrelvir and ritonavir in COVID-19 patients with end stage renal disease on intermittent haemodialysis
View ORCID ProfileTilman Lingscheid, Martina Kinzig, Anne Krüger, Nils Müller, Georg Bölke, View ORCID ProfilePinkus Tober-Lau, Friederike Münn, Helene Kriedemann, View ORCID ProfileMartin Witzenrath, View ORCID ProfileLeif E. Sander, Fritz Sörgel, View ORCID ProfileFlorian Kurth
doi: https://doi.org/10.1101/2022.08.19.22277959
Tilman Lingscheid
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
Martina Kinzig
2IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, 90562, Nürnberg-Heroldsberg, Germany
Anne Krüger
3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany
Nils Müller
3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany
Georg Bölke
3Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Nephrology and Intensive Care, Augustenburger Platz 1, 13353 Berlin, Germany
Pinkus Tober-Lau
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
Friederike Münn
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
Helene Kriedemann
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
Martin Witzenrath
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
4German Center for Lung Research, DZL, Berlin, Germany
Leif E. Sander
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
4German Center for Lung Research, DZL, Berlin, Germany
5Berlin Institute of Health, Berlin, Germany
Fritz Sörgel
2IBMP – Institute for Biomedical and Pharmaceutical Research, Paul-Ehrlich-Straße 19, 90562, Nürnberg-Heroldsberg, Germany
6Institute of Pharmacology, West German Heart and Vascular Centre, University of Duisburg-Essen, 45147 Essen, Germany
Florian Kurth
1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Infectious Diseases and Respiratory Medicine, Augustenburger Platz 1, 13353 Berlin, Germany
7Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, Bernhard-Nocht-Straße 74, 20359 Hamburg, Hamburg, Germany

Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted August 22, 2022.
Pharmacokinetics of nirmatrelvir and ritonavir in COVID-19 patients with end stage renal disease on intermittent haemodialysis
Tilman Lingscheid, Martina Kinzig, Anne Krüger, Nils Müller, Georg Bölke, Pinkus Tober-Lau, Friederike Münn, Helene Kriedemann, Martin Witzenrath, Leif E. Sander, Fritz Sörgel, Florian Kurth
medRxiv 2022.08.19.22277959; doi: https://doi.org/10.1101/2022.08.19.22277959
Pharmacokinetics of nirmatrelvir and ritonavir in COVID-19 patients with end stage renal disease on intermittent haemodialysis
Tilman Lingscheid, Martina Kinzig, Anne Krüger, Nils Müller, Georg Bölke, Pinkus Tober-Lau, Friederike Münn, Helene Kriedemann, Martin Witzenrath, Leif E. Sander, Fritz Sörgel, Florian Kurth
medRxiv 2022.08.19.22277959; doi: https://doi.org/10.1101/2022.08.19.22277959
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)